
Life Healthcare 2025: Expansion and innovation pay off with strong interim performance.
Loading player...
GUEST – Peter Wharton-Hood, chief executive officer at Life Healthcare
Life Healthcare Group Holdings Limited has announced its interim results for the six months ended 31 March 2025, highlighting robust operational growth, strategic capacity expansion, and continued investment in key healthcare initiatives across Southern Africa.
“We are pleased with the solid financial results from our core operations, particularly the growth in normalised earnings per share. Our balance sheet remains strong, with net debt to normalised EBITDA at 0.65 times, well within our covenant requirement of 3.5 times.
"Cash generated from continuing operations was R2bn, representing 105.3% of normalised EBITDA, enabling us to confidently invest in strategic growth projects across both our acute hospitals and complementary services,” said Pieter van der Westhuizen, chief financial officer.
This strong financial foundation underpins Life Healthcare’s operational progress and its continued investment in meeting rising demand for high-quality healthcare across the region.
Life Healthcare Group Holdings Limited has announced its interim results for the six months ended 31 March 2025, highlighting robust operational growth, strategic capacity expansion, and continued investment in key healthcare initiatives across Southern Africa.
“We are pleased with the solid financial results from our core operations, particularly the growth in normalised earnings per share. Our balance sheet remains strong, with net debt to normalised EBITDA at 0.65 times, well within our covenant requirement of 3.5 times.
"Cash generated from continuing operations was R2bn, representing 105.3% of normalised EBITDA, enabling us to confidently invest in strategic growth projects across both our acute hospitals and complementary services,” said Pieter van der Westhuizen, chief financial officer.
This strong financial foundation underpins Life Healthcare’s operational progress and its continued investment in meeting rising demand for high-quality healthcare across the region.